184 related articles for article (PubMed ID: 16278051)
1. 5-Lipoxygenase (ALOX5) and FLAP (ALOX5AP) gene polymorphisms as factors in vascular pathology and Alzheimer's disease.
Manev H; Manev R
Med Hypotheses; 2006; 66(3):501-3. PubMed ID: 16278051
[TBL] [Abstract][Full Text] [Related]
2. 5-Lipoxygenase gene polymorphism and onset of Alzheimer's disease.
Manev H
Med Hypotheses; 2000 Jan; 54(1):75-6. PubMed ID: 10790729
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness.
Kim SH; Bae JS; Suh CH; Nahm DH; Holloway JW; Park HS
Allergy; 2005 Jun; 60(6):760-5. PubMed ID: 15876305
[TBL] [Abstract][Full Text] [Related]
4. Candidate genes of the 5-lipoxygenase pathway in acute coronary syndrome: a pilot study.
Wung SF; Aouizerat BE
Biol Res Nurs; 2008 Apr; 9(4):280-92. PubMed ID: 18398223
[TBL] [Abstract][Full Text] [Related]
5. The Sp1/Egr1-tandem repeat polymorphism in the 5-lipoxygenase gene promoter is not associated with late onset Alzheimer disease.
Alvarez V; González P; Corao AI; Menéndez M; Lahoz CH; Martínez C; Calatayud M; Morales B; Coto E
Alzheimer Dis Assoc Disord; 2008; 22(2):177-80. PubMed ID: 18525291
[TBL] [Abstract][Full Text] [Related]
6. Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population.
Sayers I; Barton S; Rorke S; Sawyer J; Peng Q; Beghé B; Ye S; Keith T; Clough JB; Holloway JW; Sampson AP; Holgate ST
Clin Exp Allergy; 2003 Aug; 33(8):1103-10. PubMed ID: 12911785
[TBL] [Abstract][Full Text] [Related]
7. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease.
Maloney B; Ge YW; Alley GM; Lahiri DK
J Neurochem; 2007 Nov; 103(3):1237-57. PubMed ID: 17854398
[TBL] [Abstract][Full Text] [Related]
8. The pathogenesis of Alzheimer's disease.
Small GW
J Clin Psychiatry; 1998; 59 Suppl 9():7-14. PubMed ID: 9720481
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator.
Mutter J; Naumann J; Sadaghiani C; Schneider R; Walach H
Neuro Endocrinol Lett; 2004 Oct; 25(5):331-9. PubMed ID: 15580166
[TBL] [Abstract][Full Text] [Related]
10. 5-Lipoxygenase pathway gene polymorphisms: lack of association with asthma in a Spanish population.
Torres-Galván SM; Cumplido JA; Buset N; Caballero-Hidalgo A; Blanco C; Hernández E; Carrillo T
J Investig Allergol Clin Immunol; 2009; 19(6):453-8. PubMed ID: 20128419
[TBL] [Abstract][Full Text] [Related]
11. S-adenosyl methionine: A connection between nutritional and genetic risk factors for neurodegeneration in Alzheimer's disease.
Tchantchou F; Graves M; Ortiz D; Chan A; Rogers E; Shea TB
J Nutr Health Aging; 2006; 10(6):541-4. PubMed ID: 17183426
[TBL] [Abstract][Full Text] [Related]
12. [Molecular genetics of apolipoprotein E and its receptors, implications for genetic risk factors of Alzheimer's disease].
Okuizumi K; Tsuji S
Tanpakushitsu Kakusan Koso; 1996 Aug; 41(10):1460-4. PubMed ID: 8741397
[No Abstract] [Full Text] [Related]
13. Novel polymorphism of the 5-lipoxygenase activating protein (FLAP) promoter gene associated with asthma.
Koshino T; Takano S; Kitani S; Ohshima N; Sano Y; Takaishi T; Hirai K; Yamamoto K; Morita Y
Mol Cell Biol Res Commun; 1999 Jul; 2(1):32-5. PubMed ID: 10527888
[TBL] [Abstract][Full Text] [Related]
14. Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures.
Kamboh MI; Minster RL; Feingold E; DeKosky ST
Mol Psychiatry; 2006 Mar; 11(3):273-9. PubMed ID: 16302009
[TBL] [Abstract][Full Text] [Related]
15. Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of stroke: a HuGE gene-disease association review and meta-analysis.
Zintzaras E; Rodopoulou P; Sakellaridis N
Am J Epidemiol; 2009 Mar; 169(5):523-32. PubMed ID: 19126581
[TBL] [Abstract][Full Text] [Related]
16. Genetics of Alzheimer's disease.
Burke JR; Roses AD
Int J Neurol; 1991-1992; 25-26():41-51. PubMed ID: 11980062
[TBL] [Abstract][Full Text] [Related]
17. [Apolipoprotein E4 and Alzheimer's disease].
Mori S
Nihon Rinsho; 2001 Mar; 59 Suppl 3():812-7. PubMed ID: 11347179
[No Abstract] [Full Text] [Related]
18. Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.
Poole EM; Bigler J; Whitton J; Sibert JG; Potter JD; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):502-8. PubMed ID: 16537708
[TBL] [Abstract][Full Text] [Related]
19. [Genes in Alzheimer's disease].
Hoenicka J
Rev Neurol; 2006 Mar 1-15; 42(5):302-5. PubMed ID: 16538594
[TBL] [Abstract][Full Text] [Related]
20. [Genetic aspects of Alzheimer disease].
Øksengård AR; Engedal K
Tidsskr Nor Laegeforen; 2002 Feb; 122(5):530-1. PubMed ID: 11961985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
